Ceapro Inc. (CVE:CZO – Get Free Report)’s share price dropped 11.8% during mid-day trading on Tuesday . The company traded as low as C$0.23 and last traded at C$0.23. Approximately 5,849 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07. The company has a market capitalization of C$17.62 million, a PE ratio of -3.75 and a beta of 1.38. The stock’s fifty day simple moving average is C$0.22 and its 200-day simple moving average is C$0.23.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- How to Start Investing in Real Estate
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is the Hang Seng index?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- What is Forex and How Does it Work?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
